SurModics Announces Commencement of Tender Offer to Purchase up to $55 Million of Its Common Stock

Loading...
Loading...
SurModics, Inc.
SRDX
, a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industries, today announced it has commenced a tender offer to purchase up to $55 million of its common stock through a modified “Dutch auction” tender offer, at a price per share not less than $17.00 and not greater than $19.00. On August 3, 2012, the last reported sale price of SurModics' Common Stock was $17.57 per share, with an average closing price of $15.79 over the last three months. If the tender offer is fully subscribed, the Company will purchase shares representing approximately 16.5% to 18.4% of the Company's outstanding shares of common stock as of July 31, 2012. The tender offer will expire at 5:00 p.m., Eastern Daylight Time, on September 5, 2012, unless the offer is extended.
Posted In: NewsOfferings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...